GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Current Liabilities

Galderma Group AG (XSWX:GALD) Other Current Liabilities : CHF671 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Current Liabilities?

Galderma Group AG's other current liabilities for the quarter that ended in Jun. 2024 was CHF671 Mil.

Galderma Group AG's quarterly other current liabilities stayed the same from . 20 (CHF0 Mil) to Jun. 2023 (CHF0 Mil) but then increased from Jun. 2023 (CHF0 Mil) to Jun. 2024 (CHF671 Mil).

Galderma Group AG Other Current Liabilities Historical Data

The historical data trend for Galderma Group AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Current Liabilities Chart

Galderma Group AG Annual Data
Trend
Other Current Liabilities

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Other Current Liabilities - -

Galderma Group AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Galderma Group AG Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Current Liabilities
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XTAE:TEVA NSE:DIVISLAB VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257
Traded in Other Exchanges
GALDY:USA GDERF:USA GALDz:UK
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines